The expression of the linked but reciprocally imprinted Igf2 and H19 genes is activated in adult liver in the course of tumor development. By in situ hybridization analysis we have shown that both the Igf2 and H19 RNAs are expressed in the majority of the neoplastic nodules, and that hepatocellular carcinomas are developed in an experimental model of liver carcinogenesis. H19 is also highly activated in smaller and less distinct hyperplastic regions. The few neoplastic areas showing Igf2 but no H19 RNA display loss of the maternally inherited allele at the Igf2/H19 locus. These data are compatible with the existence of a common activation mechanism of these two genes during liver carcinogenesis and with a stronger H19 induction in the pre-neoplastic lesions. By using mice carrying a deletion of the H19 endodermal enhancer, we show that this regulatory element is necessary for the activation of the Igf2 and H19 genes upon induction of liver carcinogenesis. Furthermore, multiple sites of the H19 endodermal enhancer region become hypersensitive to DNase I when the carcinogenesis process is induced. Lastly, liver tumors developed in mice paternally inheriting the H19 enhancer deletion are found to have marked growth delays, increased frequency of apoptotic nuclei, and lack of Igf2 mRNA expression, thus indicating that this regulatory element plays a major role in the progression of liver carcinogenesis, since it is required for the activation of the anti-apoptotic Igf2 gene. Oncogene (2000) 19, 6376 ± 6385.
Introduction
The genes coding for the Insulin-like Growth Factor 2 (Igf2) and the untranslated H19 transcript lie 100 Kb apart on the distal portion of the mouse chromosome 7. They are members of an evolutionary conserved cluster of genes regulated by genomic imprinting (Tilghman, 1999) . This mechanism results in the expression of one parental allele and repression of the other. Igf2 and H19 are reciprocally imprinted, the former being expressed only from the paternal allele and the latter exclusively from the maternal one. Although they are activated on dierent homologous chromosomes, the Igf2 and H19 genes are coordinately transcribed during development and shut o after birth in the majority of tissues. A molecular explanation for this behavior was given by the observation that the deletion of an enhancer located 3' downstream of the H19 gene aected in cis the expression of the active Igf2 and H19 alleles in embryonal tissues of endodermal origin (Leighton et al., 1995) .
Location of the enhancer appeared essential for reciprocal imprinting, since moving the regulatory elements midway between the Igf2 and H19 genes resulted in reactivation of the maternal Igf2 allele (Webber et al., 1998) . Consistent with the hypothesis that a chromatin boundary lies between Igf2 and H19 and insulates the former gene from the enhancer, an element (ICR) showing enhancer-blocking activity has been identi®ed upstream of H19 (Hark et al., 2000; Bell and Felsenfeld, 2000) . The paternally inherited ICR is methylated, and thus binding of the protein CTCF to the ICR is prevented by CpG methylation, suggesting that the insulator is inactivated on the paternal allele, thereby allowing access of the enhancer to the Igf2 promoters.
The product of the Igf2 gene is a broad-spectrum mitogen that plays an important role in the control of prenatal growth (DeChiara et al., 1990) . IGF2 expression is frequently activated in human cancers and its overexpression has been implicated in the pathogenesis of overgrowth diseases (Toretsky and Helman, 1996; Li et al., 1998; Reik and Maher, 1997; Morison et al., 1996; Sperandeo et al., 2000) . In the mouse, Igf2 is activated in experimental liver and pancreas carcinogenesis and its deletion aects tumor formation (Ueno et al., 1988; Norstedt et al., 1988; Takagi et al., 1992; Casola et al., 1995; Haddad and Held, 1997; Christofori et al., 1994) .
The IGF2 mRNA is transcribed from three promoters in human and mouse embryos (Zarrilli et al., 1994) . Dierential activation of these promoters has been observed in human and experimental cancers (Ueno et al., 1988; Zarrilli et al., 1994) . Although several transcription factors involved in neoplastic transformation have been reported to bind and regulate in vitro-transfected IGF2 promoter fragments, no information has been obtained so far on the mechanisms responsible for the activation of this gene during in vivo carcinogenesis (Zhang et al., 1996 (Zhang et al., , 1998 Lee et al., 1998; Caricasole and Ward, 1993; Drummond et al., 1992; Kim et al., 1992) .
We have previously reported that the Igf2 and H19 genes were reactivated during SV40 T antigendependent liver carcinogenesis, their imprinting status was maintained, and their maternally-inherited alleles were frequently lost in hepatocellular carcinomas (Casola et al., 1995) . In this study, we show by in situ hybridization analysis that the activation patterns of the Igf2 and H19 genes during liver carcinogenesis are consistent with the existence of a common regulatory mechanism. The induction of the liver carcinogenesis process in mice inheriting a deletion of the H19 endodermal enhancer and the analysis of chromatin sites hypersensitive to DNase I present in the H19 endodermal enhancer region indicated that this regulatory element is the basis for the coordinated activation of Igf2 and H19 in liver tumors, as well as in embryo development. Furthermore, the analyses of apoptosis and latency of tumor appearance in mice paternally inheriting the H19 enhancer deletion attest to the importance of this regulatory element in the development of liver tumors.
Results
The activation patterns of the Igf2 and H19 genes during liver carcinogenesis partially overlap Mice of the CRP-Tag 60-3 line carry the simian virus (SV) 40 T antigen oncogene under the promoter of the liver-speci®c human C-reactive protein gene (Ruther et al., 1993) . The males of this transgenic line have a low but constitutive expression of the SV40 T antigen oncogene, which after formation of hyperplastic foci and neoplastic nodules, eventually leads to the development of multiple hepatocellular carcinomas by 4 ± 5 months of age. The females do not express the oncogene and do not develop tumors, unless they are treated with the bacterial lipopolysaccharide (LPS), which induces the transgene promoter. Activation of the viral oncogene triggers the liver carcinogenesis process. The expression of the Igf2 and H19 genes, which is completely shut o in the liver of adult CRPTag mice, is reactivated during carcinogenesis (Casola et al., 1995) .
We have now analysed the expression patterns of Igf2 and H19 during liver carcinogenesis by means of in situ hybridization. Figure 1 gives examples of the results obtained on CRP-Tag males (Figure 1a ± g ) and LPS-treated females (Figure 1 h ± j) . Overall, the results showed a nonuniform activation of these two genes. Igf2 mRNA accumulated in most of the areas showing the features of neoplastic nodules or hepatocellular carcinomas ( Figure 1a ,e,h). The majority of the neoplastic lesions expressing Igf2 also expressed H19, but the latter gene was also strongly activated in other smaller areas with less distinct boundaries (Figure 1b , f,i), many of which showed the characteristics of hyperplastic foci (Figure 1d ). This stronger and more diuse expression pattern of the H19 gene was even more evident in younger animals, displaying less advanced stages of liver carcinogenesis (data not shown). Some of the neoplastic nodules lacked H19 expression, but showed elevated Igf2 mRNA level (examples indicated by arrows in Figure 1a ,b,h,i). We dissected some of these regions from the surrounding parenchyma and extracted their DNA. Since the mice analysed for liver carcinogenesis were heterozygous for polymorphisms at the Igf2/H19 locus (see Materials and methods and Casola et al., 1995) , paternally and maternally-derived alleles could be distinguished by PCR in the isolated DNA. By this procedure, we showed that the Igf2-positive/H19-negative neoplastic nodules, but not the surrounding parenchymas, had lost the maternally inherited H19 and Igf2 alleles (Figure 2 ). The lack of H19 and persistence of Igf2 expression is consistent with the observation that these two genes maintain reciprocal imprinting and undergo loss of the active H19 and inactive Igf2 alleles in the liver tumors (Casola et al., 1995) . The percentage of nodules lacking H19 expression that we detected by in situ hybridization (about 15%) is consistent with the frequency of the complete H19 LOH previously observed by genotyping the isolated neoplasms (Casola et al., 1995) . These results are compatible with the hypothesis that the Igf2 and H19 genes are activated by a common mechanism during liver carcinogenesis, with H19 being more intensely up-regulated in the early lesions, and indicate that strong discrepancies in expression of these genes in the neoplastic lesions are due only to allelic losses.
The deletion of the H19 endodermal enhancer affects Igf2 and H19 expression in the early stages of liver carcinogenesis
The deletion (EnhD) of the enhancer located 3' of the H19 gene has been previously shown to cause, if maternally inherited, a reduction of H19 expression in embryonal tissues of endodermal origin and, if paternally inherited, a comparable decline of Igf2 mRNA level in the same cells (Leighton et al., 1995) . We wondered if these cis-acting elements were also involved in the reactivation of the Igf2 and H19 genes in adult liver during carcinogenesis. To address this question, the females generated by reciprocal crosses between EnhD heterozygotes and CRP-Tag homozygotes were treated with LPS for 15 days to induce the Tag oncogene and activate the carcinogenesis process. Igf2 and H19 expression was then analysed in the liver of these animals by RNase protection assay. As shown in Figure 3 , LPS treatment caused more than 150-and more than 800-fold activation of the Igf2 and H19 genes, respectively, in the mice carrying the CRP-Tag transgene and the wild-type enhancer (Enhwt). However, the CRP-Tag mice inheriting the EnhD from their mother (MatEnhD) and the Enhwt from their father had undetectable H19 expression, either before (data not shown) or after the LPS treatment (Figure 3 ), but Igf2 mRNA levels comparable to those observed in their CRP-Tag Enhwt siblings ( Figure 3) . Conversely, the CRP-Tag females paternally inheriting the EnhD (PatEnhD) did not show any Igf2 activation, either before (data not shown) or after the LPS treatment (Figure 3 ), but did express the H19 gene similarly to their CRP-Tag Enhwt sibs ( Figure 3 ). The reciprocal imprinting of the Igf2 and H19 genes is, therefore, maintained in the animals carrying the deletion of the H19 endodermal enhancer, and this regulatory element is required in cis for the activation of the paternal Igf2 and maternal H19 alleles in the early stages of the SV40 Tag-dependent liver carcinogenesis.
DNase hypersensitive sites are activated in the H19 endodermal enhancer during liver carcinogenesis Brunkow and Tilghman (1991) have previously observed that in a tissue actively expressing Igf2 and H19, such as the liver of newborn mice, the region of the H19 endodermal enhancer contain multiple sites hypersensitive to DNase I treatment. In order to determine if the chromatin structure of the enhancer is modi®ed during carcinogenesis, we studied the DNase I hypersensitivity of this region in the livers of female CRP-Tag mice treated with LPS Figure 1 In situ hybridization analysis of Igf2 and H19 expression in experimental liver carcinogenesis. Serial frozen sections of the livers derived from two 148-day old CRP-Tag male mice (a ± d and e ± g, respectively) and a LPS-treated CRP-Tag 6-month old female (h ± j) were hybridized to S for 15 days, in which we ascertained the activation of the Igf2 and H19 genes. Liver nuclei were isolated from LPS-treated and control mice and incubated with increasing concentrations of DNase I. The puri®ed DNA was digested with HindIII or BamHI, blotted and hybridized with probes A or B of Figure  4a , respectively. Four hypersensitive sites were detected in the liver of LPS-treated CRP-Tag mice, but not in the untreated animals ( Figure 4b ,c). Probe A detected three DNase I hypersensitive sites, two of which were located close to the enhancer sequence ( Figure 4b ). Probe B hybridized to a broad 1.5 Kb band, corresponding to a DNase hypersensitive site located 2 Kb 3' downstream of the enhancer sequences (Figure 4c ). Taken together, these results indicate that multiple sites of the H19 endodermal enhancer region become more accessible to DNase I upon induction of liver carcinogenesis as well as during prenatal development.
Paternal inheritance of the H19 EnhD delays liver tumor formation by reducing Igf2 expression and increasing apoptosis of the hepatocytes It has been shown that the deletion of the paternal Igf2 allele aects tumor formation (Christofori et al., 1994; Haddad and Held, 1997) . We therefore asked which eect had the paternal inheritance of the EnhD on liver carcinogenesis. For this purpose, male EnhD heterozygotes were crossed with female CRP-Tag homozygotes and liver tumor development was analysed in the CRP-Tag Enhwt and CRP-Tag PatEnhD progeny. Male mice were sacri®ced between 4 and 5 months of age and liver tumors were scored for size and number occurring in each animal. In general, the percentage of CRP-Tag Enhwt mice showing liver tumors larger than 3 mm increased from 21% by 120 days to about 80% by 141 and 148 days of age ( Figure 5 ). However, only 11 and 37% of the CRP-Tag PatEnhD mice developed tumors when they were 141-and 148-days old, respectively. In addition, the number of tumors occurring in each animal and their size were signi®cantly smaller in PatEnhD than Enhwt mice (Table 1 ). These results demonstrate that the paternal allele of the H19 endodermal enhancer play an active role in the progression of liver tumors.
Liver sections derived from 148 days-old male CRPTag PatEnhD mice were analysed by in situ hybridization with the Igf2-and H19-speci®c probes. Contrary to the results obtained with the CRP-Tag Enhwt mice, no expression of the Igf2 gene was observed in these tissues, not even in the neoplastic nodules (Figure 6a,  d) . However, the expression pattern of the H19 gene was similar to that of the Enhwt mice (Figure 6b ), including the ®nding of some nonexpressing nodules (Figure 6e ). In order to quantify the levels of the Igf2 and H19 RNAs in the liver tumors developed in the PatEnhD mice and their Enhwt sibs, we dissected several neoplasms from 148-day old animals, puri®ed the RNA, and analysed the expression of Igf2 and H19 by Northern blot hybridization and RNase protection assay ( Figure 7 and Table 2) . The Igf2 mRNA level of the Enhwt tumors exceeded that of the PatEnhD neoplasms by at least two orders of magnitude. These results indicate that the active Igf2 allele in cis requires the H19 endodermal enhancer for its expression in the late as well as early stages of liver carcinogenesis.
A total of 4/12 Enhwt and 1/6 PatEnhD tumors showed very low H19 expression ( Figure 7 and Table  2 ). Genotype analysis showed that this was due to the loss of the maternally inherited allele at the Igf2/H19 locus (data not shown).
Apoptosis and cell proliferation were analysed in the liver sections by TdT-mediated dUTP-nick-end labeling (TUNEL) and immunostaining with anti-Ki67 antibodies, respectively. The results obtained showed that the percentage of apoptotic cells detected in the 148-day old male CRP-Tag PatEnhD mice was at least threefold higher than in the Enhwt sibs (Figure 8a,b) . Intense Ki-67-speci®c immunostaining was observed in the neoplastic nodules and hyperplastic foci of both PatEnhD and Enhwt mice, with comparable density of positive nuclei per neoplastic lesion in the two mouse strains (Figure 8c,d ). Altogether these results indicate that the delayed tumor development observed in the 
Discussion
The expression of the IGF2 gene is activated in a variety of human cancers and the encoded growth factor is believed to play an important role in tumor development (Toretsky and Helman, 1996) . Models of experimental carcinogenesis provide useful tools for investigating the function of this peptide and the mechanisms of gene activation during tumor formation. This study shows that the Igf2 and H19 genes use the H19 endodermal enhancer for their transcriptional activation during liver carcinogenesis. Consistent with the role proposed for Igf2, mice lacking activation of this gene as a consequence of the enhancer deletion displayed a strong delay in tumor growth.
The Igf2 gene has a complex transcription unit, which lies about 100 Kb from H19. In vitro studies showed that the Igf2 and H19 promoters are bound and independently regulated by several transcription factors, some of which are involved in the control of Figure 4 Eect of the induction of liver carcinogenesis on DNase I hypersensitivity of the H19 endodermal enhancer region in female CRP-Tag mice. Nuclei were isolated from untreated and LPS-treated female CRP-Tag mice and incubated with 0, 2.5, 5, 7.5, 11, 16.5, 25 and 50 mg/ml DNase I for 5 min at 238C. Genomic DNA was puri®ed, digested to completion with HindIII (b) or BamHI (c), blotted and hybridized to probes A or B, respectively. The arrows indicate the DNase I cleavage products of the 7.2 Kb HindIII and 11.4 BamHI full-length fragments. A diagram showing the relative positions of the H19 gene (box), the two H19 endodermal enhancer elements described by Yoo-Warren et al. (1988) (circles), relevant restriction sites, probes, and identi®ed hypersensitive sites (HS1 ± 4, indicated by vertical arrows) is reported in (a) cell proliferation (Zhang et al., 1996 (Zhang et al., , 1998 Lee et al., 1998; Caricasole and Ward, 1993; Drummond et al., 1992; Kim et al., 1992; Dugimont et al., 1998) .
Nevertheless, in this study and in that of Leighton et al. (1995) , the investigation of animals with targeted mutations shows that the use of an enhancer located far from the transcription units is a prerequisite for activation of the individual promoters and allows the Igf2 and H19 genes to be coordinately expressed during embryo development, down-regulated after birth, and re-expressed upon tumor formation. The in situ hybridization analysis demonstrated that, although both Igf2 and H19 were activated in the neoplastic nodules and hepatocellular carcinomas, H19 RNA could also be detected in the less advanced hyperplastic areas. Interestingly, H19 but not Igf2 is activated during adult liver regeneration (Pachnis et al., 1984; Norstedt et al., 1988) . This behavior, which may be due to the proximity of the enhancer to the H19 gene, indicates that the H19 RNA is a sensitive marker for cell proliferation in adult liver.
The chromatin of the H19 endodermal enhancer becomes hypersensitive to DNase treatment upon induction of the SV40 T antigen oncogene in the liver, suggesting that protein-DNA interactions, which do Mice paternally inheriting the deletion of the H19 endodermal enhancer not occur at these sites in the normal adult liver, are activated when tumorigenesis is triggered. The eect of the deletion of the H19 endodermal enhancer on Igf2 expression in the liver tumors (42 log-dierence) is even more dramatic than in embryonal tissues (1 log, see Leighton et al., 1995) , suggesting that this regulatory region plays a primary role in the reactivation of this gene in adult liver. Cell transformation by SV40 T antigen expression is exerted by inactivation of p53 and the members of the pRb family (DeCaprio, 1999) . However, the clonality of the T antigendependent liver carcinogenesis indicates that additional events, secondary to the induction of the viral oncogene, are required for tumor formation (Ruther et al., 1993) . Which event is directly responsible for the activation of the Igf2/H19 unit in tumors remains to be de®ned.
Liver tumorigenesis is delayed by more than 3 weeks in the PatEnhD mice with respect to the Enhwt sibs. Both number of neoplasms per animal and average size are decreased. Immunostaining for a cell proliferation marker and analysis of DNA damage by the TUNEL assay indicated that the frequency of apoptotic cells in the PatEnhD tumors was dramatically higher than in the Enhwt tumors, while proliferative activity was comparable. This result con®rms previous data indicating that Igf2 and the receptor mediating most of its biological eects, the IGF-IR, are potent survival factors (Christofori et al., 1994; Rubin and Baserga, 1995; Werner and Le Roith, 1997) . Naik et al. (1996) and Allemand et al. (1995) observed that apoptosis is activated in the preneoplastic stages of SV40 T antigen-induced tumorigenesis. The activation of an anti-apoptotic factor, such as Igf2, could represent the limiting step for the progression to liver neoplasia.
Relaxation of IGF2 imprinting occurs frequently in human cancers and likely contributes to the induction of this gene by doubling the active gene dosage (Feinberg, 1999) . In contrast, the tumors developed in the CRP-Tag PatEnhD mice tightly maintained the imprinting of the Igf2 gene, thus causing the lack of Igf2 expression. Interestingly, Igf2 imprinting was conserved also in the liver tumors developed in mice carrying a null paternal Igf2 allele (Igf2 +/7) and the SV40 Tag oncogene, but was lost in the TGFainduced Igf2 +/7 hepatocellular carcinomas and SV40 Tag-dependent Igf2 +/7 and Igf2 7/+ pancreatic b-cell carcinomas. These results suggest that the molecular events occurring in the various carcinogenesis systems dierentially aect the maintenance of the Igf2 imprinting status (Haddad and Held, 1997; Harris et al., 1998; Christofori et al., 1994 Christofori et al., , 1995 .
H19 expression is extinguished in about 15% mouse liver tumors, as a consequence of the loss of the maternal copy of chromosome 7, often associated to duplication of the paternal homolog (Casola et al., 1995) . The in situ hybridization analysis showed that the lack of expression of the H19 gene is common to all the cells of these neoplasms, suggesting that the allelic loss must have originated early in tumor development, possibly conferring a growth advantage to the neoplastic cells. Consistent with the results obtained by Haddad and Held (1997) with the Igf2 null mice, we observed a loss of the maternal Igf2/H19 allele also in the PatEnhD mice, indicating that the lack of Igf2 expression does not prevent the occurrence of such events in the liver tumors.
The human IGF2 gene is normally transcribed in the adult liver from a tissue-speci®c promoter (P1), which has no counterpart in the mouse genome (Zarrilli et al., 1994) . However, the`fetal' P2 ± P4 promoters, which are homologous to the mouse P1 ± P3, are reactivated in hepatocellular carcinomas, as well as other human cancers (Sohda et al., 1996; Toretsky and Helman, 1996; Nardone et al., 1996) . In addition, the sequences of the H19 endodermal enhancer are well conserved between the mouse and human genomes and are therefore expected to work in a similar manner (Ishihara et al., 2000) . These factors lead us to state that the identi®cation of regulatory sequences, which are required for the activation of the Igf2 gene in experimental liver tumors, may be of help in the study of the molecular mechanisms leading to the development of human cancer. 
Materials and methods

Materials
Oligonucleotides were purchased from PRIMM (Milano, Italy).
32
P and 35 S-labeled isotopes were from Amersham (UK). Restriction enzymes were from New England Biolabs. All other materials were of the best grade commercially available.
Animals
Mice of CRP-Tag 60-3 and H19 EnhD transgenic line have been previously described (Ruther et al., 1993; Leighton et al., 1995) . In order to perform the carcinogenesis studies in mice heterozygote for polymorphisms at the Igf2 and H19 loci, animals of the CRP-Tag 60-3 line were maintained in a Balb/c background and the H19 EnhD mice in a C57-Black/6 background. Homozygote CRP-Tag 60-3 females were then mated with heterozygote EnhD males and liver carcinogenesis was analysed in their progeny. The mice of each litter were typed for the presence of the H19 EnhD, as described (Leighton et al., 1995) . The males were sacri®ced between 120 and 148 days of age. By 2 months of age, the females were treated with intraperitoneal injections of E. coli lipopolysaccharide (Sigma) for 3 months, as previously described (Ruther et al., 1993) . For the analysis of the early stages of liver carcinogenesis, the CRP-Tag Enhwt, CRPTag MatEnhD and CRP-Tag PatEnhD females were treated with LPS for 15 days (100 mg every second day). Samples of pre-neoplastic liver and liver tumors were isolated in these animals and used for histological examination, immunohistochemical, in situ hybridization, and nucleic acid analyses.
In situ hybridization
Liver samples were frozen in O.C.T. media (Tissue Tek) and stored at 7808C. Ten mm sections were cut on a cryostat, collected on slides coated with 1% gelatin (ICN), 1% chromium potassium sulphate (ICN) and stored at 7808C. The sections were ®xed in 4% paraformaldehyde in PBS for 10 min and washed twice in PBS for 5 min each. The slides were then immersed for 15 min in 0.1 M triethanolamine pH 8.00, 0.25% acetic anhydride, washed twice in 0.3 M NaCl-0.03 M sodium citrate (26SSC) for 5 min each and immersed for 10 min in 50% formamide. The sections were then dehydrated through a 50, 70, 85 and 100% ethanol series for 5 min each and air-dried.
The Igf2 probe was obtained by cloning into pGEM4Z a 382 bp fragment derived from the Igf2 coding sequence and PCR-ampli®ed from C57-Black/6 neonatal liver cDNA with primers 5'-ACCCAACTTCAGGTACCAATGG-3' and 5'-CTGTCTCCAGGTGTCATATTG-3'. The H19 probe was obtained by cloning into pGEM4Z (Promega) a 330 bp fragment derived from the H19 exon 5 and PCR-ampli®ed from C57-Black/6 DNA with primers 5'-GGCAGGATAGT-TAGCAAAGG-3' and 5'-GAGCCACTCTTGAACCTTCT-3'. The plasmids were linearized with EcoRI and transcribed in the presence of [ 35 S] CTP and T7 polymerase (Promega). For synthesis of the cDNA, 1 mg total RNA was reverse transcribed using 200 units of Superscript RT (GIBCO-BRL) in the presence of 500 nM random hexamers (Boehringer), 10 mM Dithiothreitol, 50 mM Tris-HCl-pH 8.3, 75 mM KCl, 3 mM MgCl 2 , 0.5 mM dNTP-litium salt (Boehringer) and 20 units of RNase inhibitor (Promega). Incubation was carried out at 378C for 10 min, followed by 1 h at 428C. Hybridization was performed in 50% formamide, 10% dextran sulfate, 0.03 M NaCl, 10 mM Tris-HCl pH 6.5, 5 mM EDTA, 0.01% Ficoll-0.01% bovine serum albumin-0.01% polyvinylpyrrolidone (16Denhardt's solution, Sigma), 10 mM NaH 2 PO 4 -Na 2 HPO 4 buer pH 6.8, 10 mM Dithiothreitol and 0.5 mg/ml yeast tRNA. To 50 ml of hybridization solution, 2610 6 c.p.m. of probe was added and applied to each section. The slides were covered with para®lm and incubated at 558C overnight. The sections were then washed once in 0.75 M NaCl-0.075 M sodium citrate (56SSC) and 10 mM Dithiothreitol at 508C for 30 min, twice in 50% formamide, 0.3 M NaCl-0.03 M sodium citrate (26SSC) and 10 mM Dithiothreitol at 608C for 1 h, and twice in 0.3 M NaCl-0.03 M sodium citrate (26SSC) at 378C for 10 min. The slides were then incubated in 0.3 M NaCl-0.03 M sodium citrate (26SSC) with the addition of 20 mg/ml RNase A (Sigma) at 378C for 30 min, washed twice in 50% formamide, 0.3 M NaCl-0.03 M sodium citrate (26SSC) and 10 mM Dithiothreitol at 608C for 1 h and once in 0.03 M NaCl-0.003 M sodium citrate (0.26SSC) at 558C for 15 min. The sections were then dehydrated through a 30, 60, 85 and 95% ethanol series in 0.3 M ammonium acetate for 30 s each, dipped in 100% ethanol and air-dried. Autoradiography emulsion (Kodak) was applied by dipping the slides in the solutions. Exposure time was 15 days. One in every ®ve sections was not processed for in situ hybridization, but instead was stained with Mayer's Hematoxylin solution (Sigma) and Eosin Y (Bio-Optica, Italy).
Immunohistochemistry and TUNEL
The assessment of cell proliferation in the liver sections was established by immunostaining with an anti-Ki67 polyclonal antibody (Novocastra, UK), following the procedure recommended by the manufacturer. Apoptosis was analysed by TdT-mediated dUTP nick-end labeling (TUNEL, (Gavrieli et al., 1992) ), using a kit (DeadEnd) purchased from Promega.
Isolation of DNA and RNA
Genomic DNA was prepared from tissues by standard proteinase K digestion and phenol-chloroform extraction methods (Sambrook et al., 1989) . Total RNA was isolated using the single-step acid guanidinium thiocyanate-phenolchloroform extraction method (Chomczynski and Sacchi, 1987) .
H19 and Igf2 allelotype analysis
The MspI RFLP of the H19 gene and the VNTR of the Igf2 gene were analysed by PCR as described by Casola et al. (1995) .
DNase hypersensitivity
Liver nuclei were prepared according to Reitman et al. (1993) . The yield was typically 30 A 260 units for liver. For the DNase I hypersensitive assay, nuclei were treated with increasing concentrations of DNase I (Worthington). DNase I digestion was initiated by adding 130 ml of nuclei (four A 260 units) to 70 ml of DNase I in 4 mM CaCl 2 , 12 mM Mg Cl 2 , 30 mM NaCl. The ®nal DNase I concentrations were 0, 2.5, 5, 7.5, 11, 16.5, 25, 50 mg/ml. After 5 min at 238C, digestion was stopped by addition of 200 ml of 100 mM EDTA, 100 mM NaCl, 1% SDS, 50 mM Tris-HCl pH 8.0 and 160 mg of proteinase K (Boehringer, Germany) and incubated at 378C overnight. The samples were then extracted twice with phenol-chloroform, treated with 10 mg RNase A for 1 h at 378C, extracted with phenol-chloroform, and precipitated with isopropanol. The pellets were resuspended in 50 ml 10 mM Tris-HCl pH 8.0, 1 mM EDTA. The DNA was digested to completion with BamHI or HindIII and analysed by Southern blot using the HindIII-NdeI (probe A) or HindIII-BamHI (probe B) fragments described in Figure 4 , as probes.
RNase protection
RNase protection assays were carried out with antisense probes generated as follows. The Igf2 probe was constructed by subcloning into pGEM4Z a 269 bp fragment derived from exon 6 and PCR-ampli®ed (primers 5'-GAACTTAATTGG-CACAAGCCC-3' and 5'-ACCATGCAAACTGCTCAGGA-3') from C57-Black/6 DNA. The plasmid was linearized with HindIII and transcribed with Sp6 RNA polymerase (Promega, USA). The H19 and Gapdh probes have already been described (Casola et al., 1995) , as have the reaction conditions (Ungaro et al., 1997) . RNA levels were quanti®ed by scanning the gels using a Molecular Dynamics PhosphorImager and ImageQuaNT software.
Northern and Southern blot analysis
Northern and Southern blots were carried out essentially as described (Sambrook et al., 1989; Church and Gilbert, 1984) . 32 P-labeled probes were generated by random priming extension (Feinberg and Vogelstein, 1984) from restriction fragments isolated from the rat Igf2 cDNA (Chiariotti et al., 1988) and the mouse H19 gene and 5'-end labeling of a 28mer speci®c for the mouse 28S ribosomal RNA (5'-AACGATGAGAGTAGTGGTATTTCACC-3').
